AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$OMDA

Cook Steven L. sold $28K of OMDA

Cook Steven L. (Chief Financial Officer) sold 1,108 shares of Omada Health, Inc. (OMDA) at $25.00 on 2026-08-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cook Steven L.
Published Aug 31, 2026, 9:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 9:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The sale is modest and likely reflects a pre‑planned liquidity event rather than new negative information.

02

Market read

Limited relevance; routine insider transaction with minimal market impact.

03

What to watch

Potential upcoming corporate actions not disclosed; monitor future filings.

Relevance 2/10Novelty 3/10Timing: filed Aug 31 2026

Background

Form 4 filing reports insider transactions; used by traders to gauge insider sentiment.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

CFO Steven L. Cook sold 1,108 shares for $27,700 under a 10b5-1 plan on Aug 27, 2026.

Expected impact

No significant impact expected.

Evidence & confidence

Small transaction size relative to float and typical insider activity.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

Even small insider sales can signal concerns, but context suggests routine 10b5-1 execution.

Key entities

  • Company
    Omada Health, Inc.

    Digital health platform listed on NASDAQ (OMDA).

  • Executive
    Steven L. Cook

    Chief Financial Officer of Omada Health.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

OMDA insider trading history →

Related articles

$OMDAHigh

Omada Health Earnings Call Signals Strong Growth Ahead

Omada Health (OMDA) reported Q3 revenue of $91M, up 34% YoY, with GAAP net income of $7M vs. a loss last year. Adjusted EBITDA rose to $12M. Management raised 2026 revenue guidance to $344M-$346M and adjusted EBITDA to $32M-$34M, citing strong demand for diabetes and hypertension programs. The company expects Q4 seasonality and GLP-1 coverage uncertainty.

tipranks.com
$OMDAMed

What Omada Health (OMDA) Said on Its Q3 Earnings Call

Omada Health (OMDA) expects Q4 revenue to decline due to seasonal factors, with adjusted EBITDA also moderating. The company ended Q3 with $243M in cash and no debt. CEO Sean Duffy will transition to executive chair in 2027, with Shao taking over as CEO. Omada's GLP-1 Care Track showed a 6% average weight loss at 12 weeks, according to peer-reviewed research.

finance.yahoo.com
$OMDAMedAI 8/10

Omada Health Inc (OMDA) (Q3 2026) Earnings Call Highlights: Record Revenue, Membership

Omada Health Inc (OMDA) reported record revenue and membership growth in Q3 2026. However, new enrollments are expected to decline in Q4 due to seasonality and tough comparisons. GLP-1 market dynamics and rising healthcare costs create uncertainty for 2027. Adjusted EBITDA is expected to moderate due to increased R&D and staffing. The company aims for 20%+ growth in 2027 through expanding covered lives, improving enrollment rates, and increasing engagement.

finance.yahoo.com